Company Quick10K Filing
Bio-En
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-10-17
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-19
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-29
10-Q 2016-09-30 Filed 2016-11-15
10-Q 2016-06-30 Filed 2016-08-11
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-13
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-02-19
10-Q 2013-09-30 Filed 2013-10-29
10-Q 2013-06-30 Filed 2013-07-25
10-Q 2013-03-31 Filed 2013-05-08
8-K 2020-05-12 Regulation FD
8-K 2020-04-14 Enter Agreement
8-K 2020-03-27 Regulation FD
8-K 2019-11-26 Enter Agreement, Exhibits
8-K 2019-09-22 Accountant, Exhibits
8-K 2019-08-26 Officers
8-K 2018-03-16 Enter Agreement, Control, Officers, Exhibits
8-K 2018-01-08 Enter Agreement, Exhibits

Bio-En Financials

BENH Metrics, Comps, Filings

Quarterly | Annual

Business

Bio-En Holdings Corp. (formerly Olivia Inc.) is a Delaware corporation, incorporated on August 2, 2011. The Company initially intended to participate in the bio-fuel technology industry. The Company held a license agreement for a portfolio of patents including Gravity Pressure Vessels and supporting appurtenances (“Licensed Technology”).

The Company planned to design and execute agreements to build, operate and maintain a bio-mass to energy facility on the Island of Malta, utilizing the Licensed Technology (“Facility”).

The Company was not successful in obtaining the full funding required to establish the Facility. The Company is no longer seeking to exploit the Licensed Technology and/or pursuing the establishment of the Facility.


Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Stemcell Holdings (STMM) 113% -1.0 26% 12,032,848,000 6,023,444,000 7,313,554,000 8,234,525,000 3,099,084,000 4,927,199,000 -5,115,749,000
FCCC (FCCC) 1.5 -61% 92,000,000 3,000,000 0 0 -56,000,000 -56,000,000 -82,002,000
Tapinator (TAPM) 0% 0.1 -99% 1,783,274,000 951,832,000 4,322,948,000 0 -1,761,567,000 -1,761,567,000 -260,211,000
Nogales Resources (NLRT) 0% 517,000 187,974,000 0 0 0 0 -519,000
Golden Growers Cooperative (GGRO) -0% 0% 26,919,000,000 2,171,000,000 42,425,000,000 -45,000,000 0 0 -3,508,002,000
Northern Power Systems (NPS) 22% 0.4 -27% 8,927,000,000 13,901,000,000 18,317,000,000 4,050,000,000 -2,379,000,000 -1,701,000,000 -670,002,000
Twin River Worldwide (TRWH) 0% 4.0 4% 1,070,918,000,000 808,153,000,000 393,158,000,000 0 41,775,000,000 112,100,000,000 449,559,999,000
Bio-En (BENH) 0.1 -643% 10,396,000 149,279,000 0 0 -66,818,000 -66,818,000 -4,687,000
Southwest Iowa Renewable Energy (SIRE) -1% -47.3 -1% 140,863,000,000 51,558,000,000 216,993,000,000 -1,931,000,000 -1,169,518,000 -536,518,000 25,395,999,000
Texas Republic Capital (TRCC) 0% 8.9 -5% 26,314,961,000 14,988,148,000 930,677,000 0 -1,274,149,000 -1,274,149,000 -11,327,584,000
Fannie Mae (FNM) 28.1 0% 3,494,436,000,000,000 3,484,094,000,000,000 0 0 13,025,000,000,000 119,732,000,000,000 3,361,547,999,999,000
CBA Florida (CBAI) 43.6 -1% 14,544,469,000 597,854,000 0 0 -210,911,000 -260,844,000 -11,367,563,000
Pacific Gold & Royalty (PCFG) -7.1 0 3,799,496,000 0 -2,545,000 -238,328,000 -45,194,000 319,839,000
BoxScore Brands (BOXS) 33% -8.3 -540% 312,912,000 7,564,280,000 338,295,000 110,302,000 -1,690,277,000 -701,925,000 5,793,309,000
Quest Management (QUEST) 27% -0.3 129% 12,526,000 6,028,000 45,177,000 12,318,000 16,132,000 16,164,000 -5,306,000
Zhen Ding Resources (RBTK) 0.1 48,309,900% 0 0 -483,099,000 -68,261,000 -6,097,000
Hines Global REIT (HGRI) 0% 1.7 19% 2,010,946,000,000 999,520,000,000 205,149,000,000 0 388,366,000,000 421,651,000,000 715,766,999,000
Wadena (WDN) 0% 0.0 -2,344% 11,999,000 696,137,000 87,000,000 0 -281,214,000 -278,021,000 -5,132,000
Galera Therapeutics (GRTX) 1.3 -17% 79,758,000,000 52,298,000,000 0 0 -13,351,000,000 -12,433,000,000 -15,719,002,000
Chase General (CSGN) 26% -0.5 -2% 1,563,342,000 1,016,098,000 2,493,194,000 657,636,000 -32,054,000 13,371,000 -6,929,000

Balance Sheet ($)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash20,000,0006,878,00033,176,00032,584,0009,209,00001,560,0001,498,0001,438,0001,388,0001,346,0001,304,0001,262,0001,220,0001,178,0001,136,0001,094,0001,052,0001,010,00060,00018,000019,007,0005,420,0004,848,0004,685,0004,685,000
Accounts Receivable500,00026,750,0005,698,0006,220,0005,712,0005,711,0005,711,000
Inventory
PP&E
Assets20,000,0006,878,00034,676,00033,173,0009,798,00001,560,000266,391,000261,487,000256,593,000251,707,000246,821,000241,935,000237,049,000234,163,000227,224,000222,338,000217,452,000212,618,00060,000518,00026,750,00024,705,00011,640,00010,560,00010,396,00010,396,000
Accounts Payable
Long-Term Debt
Liabilities10,558,000593,000593,00013,651,0001,247,00010,348,00047,828,000368,906,000412,091,000455,092,000513,772,000569,320,000614,986,000665,100,000706,787,000745,347,000783,154,000819,895,000858,011,000209,500,00019,710,00035,950,00047,305,00073,215,000104,365,000119,193,000149,279,000
Stockholders' Equity9,442,0006,285,00034,083,00019,522,0008,551,000-10,348,000-46,268,000-102,515,000-150,604,000-198,499,000-262,065,000-322,499,000-373,051,000-428,051,000-472,624,000-518,123,000-560,816,000-602,443,000-645,393,000-209,440,000-19,192,000-9,200,000-22,600,000-61,575,000-93,805,000-108,797,000-138,883,000
Income Statement ($)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000000000
Cost of Revenue
Gross Profit
R&D
SG&A58,907,00054,244,00048,089,0000
Tax
Net Income-9,990,000-3,157,000-10,202,000-14,561,000-10,971,000-9,694,000-58,907,000-54,244,000-48,089,000-47,895,000-63,567,000-60,434,000-50,552,000-55,001,000-44,573,000-45,499,000-42,693,000-39,747,000-42,950,000435,953,000-19,752,0006,940,000-13,400,000-32,230,000-14,992,000-19,596,000
Cash Flow ($)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-25,000-13,122,000-11,702,000-592,000-23,375,000-5,605,00028,806,000-20,586,000-60,000-50,000-42,000-28,012,000-6,542,000-5,942,000-4,042,000-11,433,000-1,782,000-10,200,00033,095,000-210,042,000-26,268,00019,007,000-572,000-163,000
Cash Investing00000000000000000000-236,310,000236,310,000000
Cash Financing20,000,000038,000,00000-3,604,0005,338,00020,524,00000027,970,0006,500,0005,900,0001,740,00010,158,000-14,153,000210,000,00026,250,0000